Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 29, Issue 3, Pages 315-348Publisher
TAYLOR & FRANCIS INC
DOI: 10.3109/08830181003792803
Keywords
neonate; sepsis; neutrophil; innate immunity
Categories
Funding
- National Institute on Alcohol Abuse and Alcoholism [AA017494, AA07577, AA09803]
Ask authors/readers for more resources
Sepsis has continuously been a leading cause of neonatal morbidity and mortality despite current advances in chemotherapy and patient intensive care facilities. Neonates are at high risk for developing bacterial infections due to quantitative and qualitative insufficiencies of innate immunity, particularly granulocyte lineage development and response to infection. Although antibiotics remain the mainstay of treatment, adjuvant therapies enhancing immune function have shown promise in treating sepsis in neonates. This article reviews current strategies for the clinical management of neonatal sepsis and analyzes mechanisms underlying insufficiencies of neutrophil defense in neonates with emphasis on new directions for adjuvant therapy development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available